[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Alvimopan Industry Research Report 2023

August 2023 | 67 pages | ID: AD0BD2526977EN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting ?-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.

Highlights

The global Alvimopan market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.

Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alvimopan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alvimopan.

The Alvimopan market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Alvimopan market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alvimopan manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Merck
  • Teva Pharmaceutical Industries Ltd
  • MSN Life Sciences Private Ltd
Product Type Insights

Global markets are presented by Alvimopan type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Alvimopan are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

Alvimopan segment by Type
  • Pharmaceutical Grade
  • Others
Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the Alvimopan market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Alvimopan market.

Alvimopan segment by Application
  • Pharmaceutical
  • Other
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Alvimopan market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alvimopan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Alvimopan and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Alvimopan industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alvimopan.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Alvimopan manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Alvimopan by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Alvimopan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions
  • Which product segment grabbed the largest share in the Product Name market?
  • How is the competitive scenario of the Product Name market?
  • Which are the key factors aiding the Product Name market growth?
  • Which are the prominent players in the Product Name market?
  • Which region holds the maximum share in the Product Name market?
  • What will be the CAGR of the Product Name market during the forecast period?
  • Which application segment emerged as the leading segment in the Product Name market?
  • What key trends are likely to emerge in the Product Name market in the coming years?
  • What will be the Product Name market size by 2028?
  • Which company held the largest share in the Product Name market?
LIST OF TABLES

Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Alvimopan Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Alvimopan Sales (KG) of Manufacturers (2018-2023)
Table 7. Global Alvimopan Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Alvimopan Revenue of Manufacturers (2018-2023)
Table 9. Global Alvimopan Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Alvimopan Average Price (US$/g) of Manufacturers (2018-2023)
Table 11. Global Alvimopan Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Alvimopan, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alvimopan by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Merck Company Information
Table 17. Merck Business Overview
Table 18. Merck Alvimopan Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 19. Merck Alvimopan Product Portfolio
Table 20. Merck Recent Developments
Table 21. Teva Pharmaceutical Industries Ltd Company Information
Table 22. Teva Pharmaceutical Industries Ltd Business Overview
Table 23. Teva Pharmaceutical Industries Ltd Alvimopan Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 24. Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio
Table 25. Teva Pharmaceutical Industries Ltd Recent Developments
Table 26. MSN Life Sciences Private Ltd Company Information
Table 27. MSN Life Sciences Private Ltd Business Overview
Table 28. MSN Life Sciences Private Ltd Alvimopan Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 29. MSN Life Sciences Private Ltd Alvimopan Product Portfolio
Table 30. MSN Life Sciences Private Ltd Recent Developments
Table 31. Global Alvimopan Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 32. Global Alvimopan Sales by Region (2018-2023) & (KG)
Table 33. Global Alvimopan Sales Market Share by Region (2018-2023)
Table 34. Global Alvimopan Sales by Region (2024-2029) & (KG)
Table 35. Global Alvimopan Sales Market Share by Region (2024-2029)
Table 36. Global Alvimopan Revenue by Region (2018-2023) & (US$ Million)
Table 37. Global Alvimopan Revenue Market Share by Region (2018-2023)
Table 38. Global Alvimopan Revenue by Region (2024-2029) & (US$ Million)
Table 39. Global Alvimopan Revenue Market Share by Region (2024-2029)
Table 40. North America Alvimopan Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. North America Alvimopan Sales by Country (2018-2023) & (KG)
Table 42. North America Alvimopan Sales by Country (2024-2029) & (KG)
Table 43. North America Alvimopan Revenue by Country (2018-2023) & (US$ Million)
Table 44. North America Alvimopan Revenue by Country (2024-2029) & (US$ Million)
Table 45. Europe Alvimopan Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Europe Alvimopan Sales by Country (2018-2023) & (KG)
Table 47. Europe Alvimopan Sales by Country (2024-2029) & (KG)
Table 48. Europe Alvimopan Revenue by Country (2018-2023) & (US$ Million)
Table 49. Europe Alvimopan Revenue by Country (2024-2029) & (US$ Million)
Table 50. Asia Pacific Alvimopan Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 51. Asia Pacific Alvimopan Sales by Country (2018-2023) & (KG)
Table 52. Asia Pacific Alvimopan Sales by Country (2024-2029) & (KG)
Table 53. Asia Pacific Alvimopan Revenue by Country (2018-2023) & (US$ Million)
Table 54. Asia Pacific Alvimopan Revenue by Country (2024-2029) & (US$ Million)
Table 55. Latin America Alvimopan Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. Latin America Alvimopan Sales by Country (2018-2023) & (KG)
Table 57. Latin America Alvimopan Sales by Country (2024-2029) & (KG)
Table 58. Latin America Alvimopan Revenue by Country (2018-2023) & (US$ Million)
Table 59. Latin America Alvimopan Revenue by Country (2024-2029) & (US$ Million)
Table 60. Middle East and Africa Alvimopan Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. Middle East and Africa Alvimopan Sales by Country (2018-2023) & (KG)
Table 62. Middle East and Africa Alvimopan Sales by Country (2024-2029) & (KG)
Table 63. Middle East and Africa Alvimopan Revenue by Country (2018-2023) & (US$ Million)
Table 64. Middle East and Africa Alvimopan Revenue by Country (2024-2029) & (US$ Million)
Table 65. Global Alvimopan Sales by Type (2018-2023) & (KG)
Table 66. Global Alvimopan Sales by Type (2024-2029) & (KG)
Table 67. Global Alvimopan Sales Market Share by Type (2018-2023)
Table 68. Global Alvimopan Sales Market Share by Type (2024-2029)
Table 69. Global Alvimopan Revenue by Type (2018-2023) & (US$ Million)
Table 70. Global Alvimopan Revenue by Type (2024-2029) & (US$ Million)
Table 71. Global Alvimopan Revenue Market Share by Type (2018-2023)
Table 72. Global Alvimopan Revenue Market Share by Type (2024-2029)
Table 73. Global Alvimopan Price by Type (2018-2023) & (US$/g)
Table 74. Global Alvimopan Price by Type (2024-2029) & (US$/g)
Table 75. Global Alvimopan Sales by Application (2018-2023) & (KG)
Table 76. Global Alvimopan Sales by Application (2024-2029) & (KG)
Table 77. Global Alvimopan Sales Market Share by Application (2018-2023)
Table 78. Global Alvimopan Sales Market Share by Application (2024-2029)
Table 79. Global Alvimopan Revenue by Application (2018-2023) & (US$ Million)
Table 80. Global Alvimopan Revenue by Application (2024-2029) & (US$ Million)
Table 81. Global Alvimopan Revenue Market Share by Application (2018-2023)
Table 82. Global Alvimopan Revenue Market Share by Application (2024-2029)
Table 83. Global Alvimopan Price by Application (2018-2023) & (US$/g)
Table 84. Global Alvimopan Price by Application (2024-2029) & (US$/g)
Table 85. Key Raw Materials
Table 86. Raw Materials Key Suppliers
Table 87. Alvimopan Distributors List
Table 88. Alvimopan Customers List
Table 89. Alvimopan Industry Trends
Table 90. Alvimopan Industry Drivers
Table 91. Alvimopan Industry Restraints
Table 92. Authors 12. List of This Report

LIST OF FIGURES

Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. AlvimopanProduct Picture
Figure 5. Global Alvimopan Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Alvimopan Market Size (2018-2029) & (US$ Million)
Figure 7. Global Alvimopan Sales (2018-2029) & (KG)
Figure 8. Global Alvimopan Average Price (US$/g) & (2018-2029)
Figure 9. Pharmaceutical Grade Product Picture
Figure 10. Others Product Picture
Figure 11. Pharmaceutical Product Picture
Figure 12. Other Product Picture
Figure 13. Global Alvimopan Revenue Share by Manufacturers in 2022
Figure 14. Global Manufacturers of Alvimopan, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of Alvimopan, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 Alvimopan Players Market Share by Revenue in 2022
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. Global Alvimopan Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 19. Global Alvimopan Sales by Region in 2022
Figure 20. Global Alvimopan Revenue by Region in 2022
Figure 21. North America Alvimopan Market Size by Country in 2022
Figure 22. North America Alvimopan Sales Market Share by Country (2018-2029)
Figure 23. North America Alvimopan Revenue Market Share by Country (2018-2029)
Figure 24. United States Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Alvimopan Market Size by Country in 2022
Figure 27. Europe Alvimopan Sales Market Share by Country (2018-2029)
Figure 28. Europe Alvimopan Revenue Market Share by Country (2018-2029)
Figure 29. Germany Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Alvimopan Market Size by Country in 2022
Figure 35. Asia Pacific Alvimopan Sales Market Share by Country (2018-2029)
Figure 36. Asia Pacific Alvimopan Revenue Market Share by Country (2018-2029)
Figure 37. China Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Alvimopan Market Size by Country in 2022
Figure 47. Latin America Alvimopan Sales Market Share by Country (2018-2029)
Figure 48. Latin America Alvimopan Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East and Africa Alvimopan Market Size by Country in 2022
Figure 53. Middle East and Africa Alvimopan Sales Market Share by Country (2018-2029)
Figure 54. Middle East and Africa Alvimopan Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE Alvimopan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Alvimopan Sales Market Share by Type (2018-2029)
Figure 59. Global Alvimopan Revenue Market Share by Type (2018-2029)
Figure 60. Global Alvimopan Price (US$/g) by Type (2018-2029)
Figure 61. Global Alvimopan Sales Market Share by Application (2018-2029)
Figure 62. Global Alvimopan Revenue Market Share by Application (2018-2029)
Figure 63. Global Alvimopan Price (US$/g) by Application (2018-2029)
Figure 64. Alvimopan Value Chain
Figure 65. Alvimopan Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Alvimopan Industry Opportunities and Challenges


More Publications